Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner

FDA approves monthly dosing for J&J's Rybrevant Faspro with Lazcluze, offering faster, easier treatment for EGFR lung cancer.
Le Lézard

FDA approves RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...
IEEE

3-D Printing of PAM Hydrogel-Based Iontronic for Dual-Mode Epidermal Sensors

Abstract: The advancement of hydrogel-based epidermal sensors that integrate multifunctionality, high transparency, rapid processing, and heightened sensitivity is of significant interest. Herein, we ...
The PrintOpinion

Blackheads keep coming back? What you are doing wrong

A lmost every week in my clinic, I meet someone who shows me their nose and says, “Doctor, see these black dots? I’ve been ...

FYI: You Don’t Have to Squeeze Your Skin to Get Rid of Blackheads, According to Dermatologists

As for the skincare routine to stick to when you wanna avoid blackheads from even starting, you want to incorporate what we talked about earlier: a gentle cleanser, salicylic acid (or retinoid, or ...